196170 fundamentals
Key facts
Market capitalization19.70 TKRW
Basic EPS (TTM)2,334.57KRW
Founded2008
CEOSun-Jae Park
Websitealteogen.com
About
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
19.70 T
Price to earning ratio (P/E)
163.74xPrice to sales ratio (P/S)
134.56xMarket Cap
Net income
Revenue
Price to earning ratio (P/E)
163.74xPrice to sales ratio (P/S)
134.56xGrowth and Profitability
Company’s recent performance and margins
−200%
−100%
0%
100%
200%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−30.00 B
0.00
30.00 B
60.00 B
90.00 B
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
No dividends
196170 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company